-+ 0.00%
-+ 0.00%
-+ 0.00%

*Rocket Pharma: Phase 2 Trial of RP-A501 for Danon Disease to Resume in 1H 2026 >RCKT

Dow Jones·02/26/2026 21:03:00

Please log in to view news